Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- ViiV Healthcare presents positive 96-week data from phase III study of investigational fostemsavir in heavily treatment-experienced patients with HIV at IAS 2019
- IAS 2019: ViiV Healthcare showcasing innovation in HIV science
- GSK announces positive headline results in Phase 3 PRIMA study of ZEJULA (niraparib) for patients with ovarian cancer in the first line maintenance setting
Tweets from GSK
-
GSK @GSK
We’ll be publishing our Q2 2019 results tomorrow at 12:00 BST, 07:00 EDT. Find out more: gsk.to/2JY0aF9 $GSK
about 10 hours ago
-
GSK @GSK
We’re working with @ViiVHC and experts across the globe to find a cure for #HIV & we won’t stop until we find it. twitter.com/ViiVHC/status/…
about 12 hours ago
-
GSK @GSK
Find out more about our new approach to drug research and development as @SarahNev interviews Hal Barron, our Chief Scientific Officer and President, R&D in @FT (sub req) twitter.com/FT/status/1152…
about 1 day ago
